| 000 | 01138 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515103403.0 | ||
| 264 | 0 | _c20080108 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLachmann, Helen J | |
| 245 | 0 | 0 |
_aHigh-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cJan 2008 |
||
| 300 |
_a91-2; author reply 92-3 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAmyloidosis _xdrug therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aDexamethasone _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmortality |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoglobulin Light Chains |
| 650 | 0 | 4 |
_aMelphalan _xadministration & dosage |
| 650 | 0 | 4 |
_aMyeloablative Agonists _xadministration & dosage |
| 700 | 1 | _aWechalekar, Ashutosh D | |
| 700 | 1 | _aGillmore, Julian D | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 358 _gno. 1 _gp. 91-2; author reply 92-3 |
|
| 999 |
_c17685747 _d17685747 |
||